89bio Inc (NASDAQ: ETNB) kicked off on Tuesday, up 17.27% from the previous trading day, before settling in for the closing price of $7.70. Over the past 52 weeks, ETNB has traded in a range of $4.16-$11.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 41.04%. With a float of $141.29 million, this company’s outstanding shares have now reached $145.98 million.
Let’s look at the performance matrix of the company that is accounted for 93 employees. In terms of profitability, gross margin is 42.86%, operating margin of -1920419.05%, and the pretax margin is -1837814.29%.
89bio Inc (ETNB) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of 89bio Inc is 3.21%, while institutional ownership is 105.91%. The most recent insider transaction that took place on Apr 15 ’25, was worth 91,208. In this transaction an insider of this company sold 15,329 shares at a rate of $5.95, taking the stock ownership to the 328,323 shares. Before that another transaction happened on Apr 15 ’25, when Company’s Officer proposed sale 15,329 for $5.95, making the entire transaction worth $91,171.
89bio Inc (ETNB) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.04% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.04% during the next five years compared to 32.21% growth over the previous five years of trading.
89bio Inc (NASDAQ: ETNB) Trading Performance Indicators
Take a look at 89bio Inc’s (ETNB) current performance indicators. Last quarter, stock had a quick ratio of 18.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.50 in the next quarter and is forecasted to reach -2.16 in one year’s time.
Technical Analysis of 89bio Inc (ETNB)
89bio Inc (NASDAQ: ETNB) saw its 5-day average volume 2.68 million, a positive change from its year-to-date volume of 2.26 million. As of the previous 9 days, the stock’s Stochastic %D was 49.06%. Additionally, its Average True Range was 0.70.
During the past 100 days, 89bio Inc’s (ETNB) raw stochastic average was set at 63.41%, which indicates a significant decrease from 83.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.99% in the past 14 days, which was lower than the 101.44% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.42, while its 200-day Moving Average is $8.19. Nevertheless, the first resistance level for the watch stands at $9.76 in the near term. At $10.48, the stock is likely to face the second major resistance level. The third major resistance level sits at $11.61. If the price goes on to break the first support level at $7.91, it is likely to go to the next support level at $6.78. Assuming the price breaks the second support level, the third support level stands at $6.06.
89bio Inc (NASDAQ: ETNB) Key Stats
The company with the Market Capitalisation of 1.32 billion has total of 145,984K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -367,080 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -71,280 K.
